You Are On:
EQUITY
Equity Analysis
  Price
    Gainers & Losers
    Out & Under Performers
    Only Buyers & Sellers
     Advances & Declines
     New Highs & Lows
     Weightage
     5 Day's Up & Down
  Volume
  Analysis
News Analysis
Corporate Info
Corporate Action
Other Market
Company News    
Glenmark Pharmaceuticals Ltd.
Change Company   
BSE Code 532296
ISIN Demat INE935A01035
Book Value 650.55
NSE Code GLENMARK
Dividend Yield(%) 0.23
Market Cap(Million) 302957.20
P/E(X) 72.80
EPS(Rs.) 14.75
Face Value(Rs.) 1  
10-Apr-2024 Glenmark Pharmaceuticals recalls 6,528 bottles of...
01-Apr-2024 Glenmark Pharmaceuticals informs about completion...
06-Mar-2024 Glenmark Pharmaceuticals informs about disclosure
19-Feb-2024 Glenmark Pharmaceuticals informs about transcript...
01-Feb-2024 Infosys, Cochin Shipyard and Glenmark Pharmaceuti...
31-Jan-2024 Glenmark Pharmaceuticals partners with Pfizer to ...
31-Jan-2024 Glenmark Pharmaceuticals, Jubilant FoodWorks and ...
30-Jan-2024 Glenmark, Ichnos launch alliance to accelerate ne...
25-Jan-2024 Glenmark Pharmaceuticals’ arm signs license agree...
25-Jan-2024 Glenmark Pharmaceuticals informs about media rele...
25-Jan-2024 Glenmark Pharmaceuticals rises as its arm signs l...
03-Jan-2024 Glenmark Pharmaceuticals launches biosimilar of p...
03-Jan-2024 Glenmark Pharmaceuticals gains on launching biosi...
03-Jan-2024 Glenmark Pharmaceuticals informs about media rele...
23-Nov-2023 Glenmark Pharmaceuticals recalling 5,856 bottles ...
Page 1 of 3
Prev || Next